• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲硫氨酸 274 不是 L 形抑制剂选择性抑制组蛋白去乙酰化酶 8(HDAC8)的决定因素。

Methionine 274 Is Not the Determining Factor for Selective Inhibition of Histone Deacetylase 8 (HDAC8) by L-Shaped Inhibitors.

机构信息

Department of Chemical Engineering and Biotechnology, University of Applied Sciences Darmstadt, Haardtring 100, 64295 Darmstadt, Germany.

出版信息

Int J Mol Sci. 2022 Oct 4;23(19):11775. doi: 10.3390/ijms231911775.

DOI:10.3390/ijms231911775
PMID:36233076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9569839/
Abstract

HDAC8 is an important target in several indication areas including childhood neuroblastoma. Several isozyme selective inhibitors of HDAC8 with L-shaped structures have been developed. A theoretical study has suggested that methionine 274 (M274) would act as a "switch" that controls a transient binding pocket, which is induced upon binding of L-shaped inhibitors. This hypothesis was experimentally examined in this study. The thermostability and functionality of HDAC8 wildtype and mutant variants with exchanged M274 were analyzed using biophysical methods. Furthermore, the binding kinetics of L-shaped and linear reference inhibitors of these HDAC8 variants were determined in order to elucidate the mode of interaction. Exchange of M274 has considerable impact on enzyme activity, but is not the decisive factor for selective recognition of HDAC8 by L-shaped inhibitors.

摘要

组蛋白去乙酰化酶 8(HDAC8)是包括儿童神经母细胞瘤在内的多个适应证领域的重要靶点。已经开发出了几种具有 L 型结构的组蛋白去乙酰化酶 8 同工酶选择性抑制剂。一项理论研究表明,蛋氨酸 274(M274)将充当“开关”,控制一个瞬时结合口袋,该口袋在结合 L 型抑制剂时被诱导。本研究对此假说进行了实验检验。使用生物物理方法分析了野生型和突变型 HDAC8 及其交换 M274 的变体的热稳定性和功能。此外,还确定了这些 HDAC8 变体的 L 型和线性参考抑制剂的结合动力学,以阐明相互作用模式。M274 的交换对酶活性有很大的影响,但不是 L 型抑制剂选择性识别 HDAC8 的决定性因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/ba709729a5ea/ijms-23-11775-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/87fb73a09d93/ijms-23-11775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/eee8e4509fa5/ijms-23-11775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/6e0ca5a27a03/ijms-23-11775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/8b6d1a4d9f0f/ijms-23-11775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/d75ee315af33/ijms-23-11775-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/53442739335c/ijms-23-11775-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/ba709729a5ea/ijms-23-11775-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/87fb73a09d93/ijms-23-11775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/eee8e4509fa5/ijms-23-11775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/6e0ca5a27a03/ijms-23-11775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/8b6d1a4d9f0f/ijms-23-11775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/d75ee315af33/ijms-23-11775-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/53442739335c/ijms-23-11775-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9569839/ba709729a5ea/ijms-23-11775-g007.jpg

相似文献

1
Methionine 274 Is Not the Determining Factor for Selective Inhibition of Histone Deacetylase 8 (HDAC8) by L-Shaped Inhibitors.甲硫氨酸 274 不是 L 形抑制剂选择性抑制组蛋白去乙酰化酶 8(HDAC8)的决定因素。
Int J Mol Sci. 2022 Oct 4;23(19):11775. doi: 10.3390/ijms231911775.
2
Mechanistic Exploration of Methionine 274 Acting as a "Switch" of the Selective Pocket Involved in HDAC8 Inhibition: An in Silico Study.蛋氨酸274作为参与HDAC8抑制的选择性口袋“开关”的机制探索:一项计算机模拟研究
ChemMedChem. 2021 Jun 17;16(12):1933-1944. doi: 10.1002/cmdc.202001004. Epub 2021 Apr 7.
3
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity.设计、合成和组蛋白去乙酰化酶 8(HDAC8)蛋白水解靶向嵌合体(PROTACs)的生物学特征及其抗神经母细胞瘤活性。
Int J Mol Sci. 2022 Jul 7;23(14):7535. doi: 10.3390/ijms23147535.
4
Kinetically selective and potent inhibitors of HDAC8.HDAC8 动力学选择性和强效抑制剂。
Biol Chem. 2019 May 27;400(6):733-743. doi: 10.1515/hsz-2018-0363.
5
Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.组蛋白去乙酰化酶 8(HDAC8)选择性抑制作用的特征分析揭示了特定的活性位点结构和功能决定因素。
J Med Chem. 2018 Nov 21;61(22):10000-10016. doi: 10.1021/acs.jmedchem.8b01087. Epub 2018 Nov 8.
6
Covalent inhibition of histone deacetylase 8 by 3,4-dihydro-2H-pyrimido[1,2-c][1,3]benzothiazin-6-imine.3,4-二氢-2H-嘧啶并[1,2-c][1,3]苯并噻嗪-6-亚胺对组蛋白去乙酰化酶 8 的共价抑制作用。
Biochim Biophys Acta Gen Subj. 2019 Mar;1863(3):577-585. doi: 10.1016/j.bbagen.2019.01.001. Epub 2019 Jan 3.
7
Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors.发现间磺酰基N-羟基苯甲酰胺类化合物作为HDAC8选择性抑制剂
Eur J Med Chem. 2018 Apr 25;150:282-291. doi: 10.1016/j.ejmech.2018.03.002. Epub 2018 Mar 6.
8
Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting.构象受限苯甲酰胺支架的特性研究及其作为高效和选择性 HDAC8 靶标的应用。
J Med Chem. 2020 Aug 13;63(15):8634-8648. doi: 10.1021/acs.jmedchem.0c01025. Epub 2020 Jul 31.
9
Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation.对组蛋白去乙酰化酶8(HDAC8)的选择性抑制可在体外和体内降低神经母细胞瘤的生长,并增强视黄酸介导的分化。
Cell Death Dis. 2015 Feb 19;6(2):e1657. doi: 10.1038/cddis.2015.24.
10
Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between HDAC2 and HDAC8.强效帕比司他(panobinostat)组蛋白去乙酰化酶抑制剂衍生物的设计:提高 HDAC2 和 HDAC8 之间同工酶选择性的分子考虑。
Mol Inform. 2019 Mar;38(3):e1800080. doi: 10.1002/minf.201800080. Epub 2018 Oct 22.

引用本文的文献

1
In Silico Exploration of the Trypanothione Reductase (TryR) of .计算机探索. 的硫氧还蛋白还原酶(TryR)
Int J Mol Sci. 2023 Nov 7;24(22):16046. doi: 10.3390/ijms242216046.
2
Continuous enzyme activity assay for high-throughput classification of histone deacetylase 8 inhibitors.用于组蛋白去乙酰化酶8抑制剂高通量分类的连续酶活性测定
Explor Target Antitumor Ther. 2023;4(3):447-459. doi: 10.37349/etat.2023.00144. Epub 2023 Jun 30.
3
Lysine Deacetylase Substrate Selectivity: Distinct Interaction Surfaces Drive Positive and Negative Selection for Residues Following Acetyllysine.

本文引用的文献

1
Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia.揭示组蛋白去乙酰化酶在肿瘤形成中的表观遗传作用及临床影响
Diagnostics (Basel). 2021 Jul 26;11(8):1346. doi: 10.3390/diagnostics11081346.
2
Mechanistic Exploration of Methionine 274 Acting as a "Switch" of the Selective Pocket Involved in HDAC8 Inhibition: An in Silico Study.蛋氨酸274作为参与HDAC8抑制的选择性口袋“开关”的机制探索:一项计算机模拟研究
ChemMedChem. 2021 Jun 17;16(12):1933-1944. doi: 10.1002/cmdc.202001004. Epub 2021 Apr 7.
3
A distal regulatory region of a class I human histone deacetylase.
赖氨酸去乙酰化酶底物选择性:与乙酰化赖氨酸后续残基结合的不同相互作用表面导致正选择和负选择。
Biochemistry. 2023 May 2;62(9):1464-1483. doi: 10.1021/acs.biochem.3c00001. Epub 2023 Apr 12.
I 类人组蛋白去乙酰化酶的远端调控区。
Nat Commun. 2020 Jul 31;11(1):3841. doi: 10.1038/s41467-020-17610-w.
4
Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors.1,3-苯并噻嗪-2-硫酮类化合物的合成及结构活性关系研究作为选择性 HDAC8 抑制剂。
Eur J Med Chem. 2019 Dec 15;184:111756. doi: 10.1016/j.ejmech.2019.111756. Epub 2019 Oct 7.
5
Histone Deacetylase Inhibitors in Cancer Therapy.组蛋白去乙酰化酶抑制剂在癌症治疗中的应用。
Curr Top Med Chem. 2018;18(28):2420-2428. doi: 10.2174/1568026619666181210152115.
6
Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.组蛋白去乙酰化酶 8(HDAC8)选择性抑制作用的特征分析揭示了特定的活性位点结构和功能决定因素。
J Med Chem. 2018 Nov 21;61(22):10000-10016. doi: 10.1021/acs.jmedchem.8b01087. Epub 2018 Nov 8.
7
The enzyme activity of histone deacetylase 8 is modulated by a redox-switch.组蛋白去乙酰化酶 8 的酶活性受氧化还原开关调节。
Redox Biol. 2019 Jan;20:60-67. doi: 10.1016/j.redox.2018.09.013. Epub 2018 Sep 27.
8
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity.基于结构的选择性组蛋白去乙酰化酶 8(HDAC8)抑制剂的设计与生物学特性及其抗神经母细胞瘤活性研究。
J Med Chem. 2017 Dec 28;60(24):10188-10204. doi: 10.1021/acs.jmedchem.7b01447. Epub 2017 Dec 15.
9
Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases.靶向组蛋白去乙酰化酶8作为癌症和神经退行性疾病的一种治疗方法。
Future Med Chem. 2016 Sep;8(13):1609-34. doi: 10.4155/fmc-2016-0117. Epub 2016 Aug 30.
10
HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells.HDAC8抑制作用可阻断SMC3去乙酰化并延迟细胞周期进程,而不影响MCF7癌细胞中黏连蛋白依赖性转录。
J Biol Chem. 2016 Jun 10;291(24):12761-12770. doi: 10.1074/jbc.M115.704627. Epub 2016 Apr 12.